Engineers in Prof. James Harris' laboratory have developed a compact optics and microfluidics device to continuously monitor the hemostatic state of patients undergoing heart surgery, dialysis or other procedures.
Stanford researchers have developed a portable particle accelerator – the SLAC Piezoelectric Accelerator Neutron Source (SPAN). When combined with an ion source and a deuterated target, this piezoelectric, high-voltage generator makes a compact neutron generator system.
Engineers in Prof. Shan Wang's laboratory have developed a patented magnetic sifter device for high throughput cell sorting. This technology employs magnetic nanobead probes to tag cells of interest from raw samples.
Researchers in Prof. Irving Weissman's lab have developed and patented antibodies and methods to prevent the formation of teratomas from human pluripotent stem cells used for regenerative medicine, cell therapy or research.
Researchers in Prof. Hemamala Karunadasa's laboratory have developed inexpensive, robust, high capacity hybrid materials for reversible or irreversible capture of halogens (chlorine, bromine, and iodine gas).
Researchers at Stanford have developed methods to identify, isolate, and use specific progenitor cell populations to generate adipose tissue and functional blood vessels in vivo.
Researchers in Prof. Gerald Crabtree's laboratory have identified the pathological mechanism for synovial sarcoma (SS) that could be used to develop targeted therapeutics. This approach aims to reverse the effects of the SS18-SSX fusion protein (the hallmark of human SS).
Researchers in Prof. Gerald Crabtree's laboratory have developed a method for identifying cancer patients that are likely to benefit from treatment with topoisomerase IIa (TOP2A) inhibitors.
Stanford researchers at the Airan Lab have developed a new method for robust and spatiotemporally precise non-invasive neuromodulation that could transform both basic and clinical neuroscience.
Researchers in Dr. Christina Smolke's lab have generated novel RNA aptamer sensors that can be used to regulate gene expression in response to the clinically relevant drug folinic acid.
This light-weight, hand-held, mechanical microfluidic device is designed to perform complex protocols in low resource settings without a power source or external control element. Developed by researchers in Prof.
Dr. Mark Kay and colleagues have created antibiotic-selectable, non-silencing plasmid vectors that can be prepared by conventional methods and provide persistent high levels of transgene expression.
Researchers at Stanford have developed a high-throughput barcoding method that greatly improves sequencing accuracy and makes it possible to do robust single molecule profiling, since it can trace duplicate sequencing reads to their original single molecule clones.
Stanford researchers have developed a PCR-based method that detects disease-relevant, isotype-specific antibodies and can be used to diagnose allergy. Allergy is a prevalent immune hypersensitivity disease that affects more than 20% of the US population.
Researchers at Stanford have developed methods to overcome the limited packaging capacity of adeno-associated virus (AAV) vectors and enable their use in integration of large transgenes.